Reversing the immune ageing clock:lifestyle modifications and pharmacological interventions by Duggal, Niharika A
 
 
Reversing the immune ageing clock
Duggal, Niharika
DOI:
10.1007/s10522-018-9771-7
License:
Creative Commons: Attribution (CC BY)
Document Version
Publisher's PDF, also known as Version of record
Citation for published version (Harvard):
Duggal, NA 2018, 'Reversing the immune ageing clock: lifestyle modifications and pharmacological
interventions', Biogerontology, vol. 19, no. 6, pp. 481-496. https://doi.org/10.1007/s10522-018-9771-7
Link to publication on Research at Birmingham portal
General rights
Unless a licence is specified above, all rights (including copyright and moral rights) in this document are retained by the authors and/or the
copyright holders. The express permission of the copyright holder must be obtained for any use of this material other than for purposes
permitted by law.
•	Users may freely distribute the URL that is used to identify this publication.
•	Users may download and/or print one copy of the publication from the University of Birmingham research portal for the purpose of private
study or non-commercial research.
•	User may use extracts from the document in line with the concept of ‘fair dealing’ under the Copyright, Designs and Patents Act 1988 (?)
•	Users may not further distribute the material nor use it for the purposes of commercial gain.
Where a licence is displayed above, please note the terms and conditions of the licence govern your use of this document.
When citing, please reference the published version.
Take down policy
While the University of Birmingham exercises care and attention in making items available there are rare occasions when an item has been
uploaded in error or has been deemed to be commercially or otherwise sensitive.
If you believe that this is the case for this document, please contact UBIRA@lists.bham.ac.uk providing details and we will remove access to
the work immediately and investigate.
Download date: 01. Feb. 2019
REVIEW ARTICLE
Reversing the immune ageing clock: lifestyle modifications
and pharmacological interventions
Niharika A. Duggal
Received: 27 June 2018 / Accepted: 16 September 2018 / Published online: 29 September 2018
 The Author(s) 2018
Abstract It is widely accepted that ageing is
accompanied by remodelling of the immune system,
including reduced numbers of naı¨ve T cells, increased
senescent or exhausted T cells, compromise to mono-
cyte, neutrophil and natural killer cell function and an
increase in systemic inflammation. In combination
these changes result in increased risk of infection,
reduced immune memory, reduced immune tolerance
and immune surveillance, with significant impacts
upon health in old age. More recently it has become
clear that the rate of decline in the immune system is
malleable and can be influenced by environmental
factors such as physical activity as well as pharmaco-
logical interventions. This review discusses briefly our
current understanding of immunesenescence and then
focuses on lifestyle interventions and therapeutic
strategies that have been shown to restore immune
functioning in aged individuals.
Keywords Ageing  Immunesenescence 
Inflammaging
Immune ageing and health
Over the past 250 years life expectancy has increased
dramatically and is still increasing at 2 years per
decade in most countries. Advancing age is accompa-
nied by a compromised ability of older adults to
combat bacterial and viral infections (Gavazzi and
Krause 2002; Molony et al. 2017a, b), increased risk of
autoimmunity (Goronzy and Weyand 2012), poor
vaccination responses (Del Giudice et al. 2017; Lord
2013) and the re-emergence of latent infections to
produce conditions such as shingles (Schmader 2001).
All of this contributing towards increased morbidity
and mortality in older adults (Pera et al. 2015) and
indicative of reduced immunity.
Another universal feature of physiological ageing is
an increase in circulating levels of pro-inflammatory
cytokines (IL-1b, IL-6, IL8, TNFa, IFNc, and CRP)
termed ‘‘Inflammaging’’ (Franceschi et al. 2007).
Importantly, a strong association has been reported
between elevated pro-inflammatory cytokine levels in
older adults and mortality (Cohen et al. 2003), frailty
(Cesari et al. 2004), age-related chronic diseases
(Ershler and Keller 2000) and cognitive impairment
(Yaffe et al. 2003). Inflammaging is multifactorial
with some of the factors proposed to contribute to
inflammaging including: lifetime antigenic load
resulting in oxidative damage; increased DNA dam-
age, accumulation of senescent cells, increased vis-
ceral adipose tissue; decline in sex hormones and
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reduced immune regulation (Baylis et al. 2013; Singh
and Newman 2011).
Altered immunity with age is the result of remod-
elling of both the innate and adaptive arms of the
immune system, collectively termed immunesenes-
cence. Delaying or reversing the effects of ageing on
the immune system could be extremely beneficial in
maximising health and improving quality of life in
older adults (Dorshkind et al. 2009). For the cells of
the innate immune response the literature is clear that
their numbers increase with age but their function
upon challenge with pathogens declines. Thus age-
associated defects have been observed in neutrophils,
monocytes/macrophages, NK cells and dendritic cells
(Fig. 1). Neutrophils are the primary immune defence
against bacterial and fungal infections and recent
studies have revealed that in addition to the well
documented reduction in phagocytosis and ROS
generation, these cells also show reduced chemotaxis
to a range of stimuli (Sapey et al. 2014) and a reduced
ability to extrude their DNA as NETs to entrap
bacteria extracellularly (Hazeldine et al. 2014). Addi-
tionally, an age-associated reduction in TLR1 expres-
sion on neutrophils has been associated with reduced
chemokine (IL8) production, reduced rescue from
apoptosis and lower expression of activation markers,
resulting from reduced bioenergetics in neutrophils
(Qian et al. 2014).
Circulating monocytes play a critical role in
defence against invading pathogens being early
responders to infection and able to act as antigen
presenting cells. Ageing affects the distribution of
monocyte subsets with a decline in classical mono-
cytes (CD14?ve CD16-ve) and increase in intermedi-
ate (CD14?ve CD16?ve) and non-classical monocytes
(CD14?ve CD16??ve) occurs with age (Seidler et al.
2010). Interestingly, non-classical monocytes express
high levels of miR-146a and exhibit a senescence
associated secretory phenotype (SASP), contributing
towards inflammaging (Ong et al. 2018). Also, age-
associated changes in platelets also contribute towards
inflammatory cytokine production by monocytes
(Campbell et al. 2018). However, monocyte cytokine
secretion in response to stimulation via TLRs is
greatly reduced with age (Metcalf et al. 2017). A
notable exception is TLR5 expression that has been
reported to increase with age, offering an opportunity
to develop improved vaccines for older adults (Qian
et al. 2012). Retinoic acid inducible gene 1 (RIG-1)
like receptors play a key role in recognition of viral
nucleic acids and older human monocytes have intact
RIG1 signalling to activate pro-inflammatory cytoki-
nes but have a diminished IFN response (Pillai et al.
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2016; Molony et al. 2017a). Cytosolic dsDNA recep-
tor AIM2 triggers the inflammasome and is important
for control of virus infections (Guo et al. 2015).
Recently, defects in AIM2 expression have been
reported in monocytes of older adults, impairments in
caspase 1 activation upon stimulation of AIM2 has
been associated with reduced IL1b secretion (Wang
et al. 2016). These alterations in innate immune
responses to pathogens with ageing have conse-
quences for the ability of older adults to respond to
an infectious challenge. Other monocyte functions
such as wound repair (Sebastia´n et al. 2005) and
clearance of apoptotic cells (Aprahamian et al. 2008)
are also compromised in older adults.
Dendritic cells play a key role in initiating
pathogen-specific adaptive immune responses and
have been divided into two subsets—myeloid DCs
and plasmacytoid DCs. A reduction in plasmacytoid
DCs and unaltered frequency of myeloid DCs have
been reported in older adults (Garbe et al. 2012).
Recent data in this field has led to further division of
myeloid DCs into two subsets; CD1c?ve and CD141?-
ve mDCs. Ageing is accompanied by a decline in
peripheral CD141?ve DCs, whereas the CD1c?ve
mDCs remain unaltered (Agrawal et al. 2016). Age
associated impairments occur in DC recruitment to
lymphoid organs post antigen exposure which has
been associated with mitochondrial dysfunction
(Chougnet et al. 2015). Surprisingly, the age associ-
ated ability of DCs to phagocytose C.albicans remains
intact (Do Nascimento et al. 2015). Also, the ability of
DCs to induce T cell proliferation and IFNc secretion
is impaired in older adults, resulting in impairments in
vaccine responses (Panda et al. 2010; Sridharan et al.
2011). Another age associated dysfunction of DCs is
in their ability to efficiently activate NK cells which is
likely to contribute to impaired tumour immunity
(Guo et al. 2014).
NK cells are innate cytotoxic lymphocytes that play
an essential role in defence against viral infections and
malignancies and they also kill senescent cells thus
contributing to delaying the ageing phenotype (Sagiv
et al. 2013). Ageing is accompanied by an increase in
NK cell numbers, due to expansion of CD56dim NK
cells (Le Garff-Tavernier et al. 2010; Almeida-
Oliveira et al. 2011). CMV seropositivity and proin-
flammatory status (Campos et al. 2014) are contrib-
utors towards altered NK cell subset distribution. The
expression of NK cell receptors; NKp46 and NKp30
has been shown to decline with age, whereas NKG2D
expression remains unaltered (Solana et al. 2014), as
NKG2D is required for the killing of senescent cells
(Sagiv et al. 2016) this may affect the killing ability of
NK cells towards senescent cells, though this has not
yet been shown. In this context, NK cell cytotoxicity
towards cancer cells is mediated by granule exocytosis
and is reduced with age (Almeida-Oliveira et al. 2011;
Hazeldine et al. 2012), due to reduced release of
perforin (Hazeldine et al. 2012). In contrast, NK cell
mediated antibody dependent cell cytotoxicity
(ADCC) is preserved with age (Lutz et al. 2005).
Myeloid derived suppressor cells (MDSCs) are
known to play an important role in suppression of T
cell responses (Gabrilovich and Nagaraj 2009).
Importantly, ageing is accompanied by an increase
in MDSCs, which has been linked with a higher
incidence of cancer and chronic inflammation in aged
individuals (Enioutina et al. 2011). In the adaptive
immune system, the effects of age are also significant
(Fig. 2). The thymus is devoted to T lymphocyte
differentiation and maturation and ageing is associated
with atrophy of the thymus (Mitchell et al. 2010). In
humans, thymic atrophy involves a decrease in both
stromal and thymocyte cellularity with infiltration of
adipocytes, loss of tissue organisation, reduced levels
of cytokines and hormones essential for thymopoiesis
(e.g. IL-7, KGF and Ghrelin) and upregulation of
thymosuppressive cytokines (e.g. IL-6, TNFa) with
age (Palmer 2013; Ventevogel and Sempowski 2013).
The net outcome of thymic involution is reduced naı¨ve
T cell output (Haines et al. 2009) which compromises
the ability to respond to new pathogens and vaccines.
Other hallmarks of T cell immunesenescence include:
accumulation of CD28-ve CD57?ve T cells with
shortened telomeres and reduced proliferative capac-
ity (Strioga et al. 2011), which also acquire NK cell
receptors such as KLRG1 (Weng et al. 2009) increas-
ing risk of autoimmune responses; skewing of T cell
responses towards Th17 cell differentiation (Ouyang
et al. 2011). Regulatory CD4?veCD25?veFoxp3?ve T
cells play a pivotal role in maintaining immune
homeostasis by suppressing immune responses. Age-
ing is associated with an increase in the frequency of
Tregs, which correlates with increasing incidence of
cancer in older adults (Hou et al. 2017).
As with T cells there is a decline in the frequency of
naı¨ve B cells (CD27-ve IgD?ve) and an increase in
memory B cells has also been reported (Colonna-
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Romano et al. 2006) (Fig. 2). Ageing is accompanied
by poor vaccination responses, likely due to reduced B
cell and T cell activity (Siegrist and Aspinall 2009).
Older adults generate tenfold fewer antibody secreting
cells relative to young individuals on antigenic
stimulation (Kogut et al. 2012). Additionally, the
antibodies produced by aged B cells have lower
affinity and fewer antibodies are pathogen specific
(Howard et al. 2006). A decline in CD4 T cell and
dendritic cell functioning, along with intrinsic changes
in B cells resulting in age-associated reduction in
number and size of germinal centres are all contribut-
ing factors towards the decline in antibody production
by older individuals with age (Frasca and Blomberg
2009). Further, an age associated numerical and
functional deficit in a novel subset of immunosup-
pressive CD19?ve CD24hi CD38hi B cells has been
recently reported, which might be a factor contributing
towards increased risk of systemic autoimmunity with
advancing age (Duggal et al. 2012).
As the immune system does not operate in isolation
and can bemodified by a broad range of environmental
signals, we now consider howmodification of lifestyle
could be used to improve on the reduced immune
responses of older adults.
Impact of lifestyle factors on immunesenescence
and inflammaging
Physical activity
Regular physical activity has been associated with
major health benefits including; reduced risk of
cardiovascular diseases, diabetes, stroke, sarcopenia
and mortality (Shepherd et al. 2015). However, ageing
is accompanied by a sharp decline in both duration and
intensity of physical activity and the majority of older
adults fail to meet the World Health organisation
(WHO) recommended guidelines of 150 min of
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aerobic exercise per week (World Health Organisation
2010).
Exercise in older adults has been associated with
lower levels of pro-inflammatory cytokines such as
IL6, TNFa (Gleeson et al. 2011). Physical activity
exerts an anti-inflammaging effect via several mech-
anisms. Fat mass increases with age, which has been
associated with low-grade chronic inflammation. This
is due in large part to the pro-inflammatory cytokines
secreted by fat, termed adipokines. Levels of pro-
inflammatory adipokines such as leptin and visfatin
increase with age whereas anti-inflammatory adipo-
nectin decreases (Gulcelik et al. 2013). In addition,
adipose tissue contains immune cells including
macrophages which themselves secrete pro-inflam-
matory cytokines (Vieira-Potter 2014). Regular phys-
ical activity has been associated with a reduction of
visceral and abdominal fat (Ross and Bradshaw 2009)
resulting in a reduction of pro-inflammatory cytokine
levels. Skeletal muscle itself is also a major source of
cytokines, termed myokines in the physiology litera-
ture (Hoffmann andWeigert 2017). Exercising muscle
transiently secretes less IL-6 and more anti-inflam-
matory IL-10 (Steensberg et al. 2003), providing a
counter to inflammaging.
Physical activity also has direct effects on immune
function, including in older adults. In aged humans
intervention studies ranging from 6 weeks up to
10 months, performed 1–6 times per week have
reported multiple effects on the immune system
including: improved neutrophil chemotaxis (Bartlett
et al. 2016) and phagocytosis (Sasaki et al. 2013; lower
frequency of CD16?ve monocytes that may be critical
in reducing inflammaging (Timmerman et al. 2009);
enhanced NK cell cytotoxicity (Bigley et al. 2015),
mobilisation of dendritic cells (Sucha´nek et al. 2010),
reduced memory T cells and increased T cell prolif-
eration (Shinkai et al. 1995), increased T cell telomere
length (Silva et al. 2016), improved T helper cell
functioning (Shimizu et al. 2008) and immature B cell
mobilisation (Turner et al. 2016). In a recent study we
reported that high levels of physical activity in
adulthood has a beneficial effect on thymic output
likely to be a result of improved thymic microenvi-
ronment (raised levels of IL7 and lower levels of IL6).
Additionally, we found the maintenance of peripheral
naı¨ve T cell frequency in the active older adults which
was associated with higher serum IL15 (Duggal et al.
2018). Others have shown that individuals who
perform regular exercise appear to be at a reduced
risk of mortality from infections (Lowder et al. 2005)
and participation in aerobic exercise for 3 months
before the influenza vaccination improved vaccination
responses in older adults (Kohut et al. 2004). However
it is likely that physical activity needs to be maintained
to achieve effects on vaccination responses as a study
involving a 45 min brisk walk before vaccination
showed no effect (Long et al. 2012). In summary,
regular participation in physical activity is a non-
invasive, mostly cost neutral anti-immunesenescence
and anti-inflammaging therapy.
Caloric restriction
Restriction of food intake to approximately 30% of
ad libitum calorie intake (caloric restriction), without
malnutrition, is a robust means of increasing longevity
and delaying onset of age-associated diseases in a
variety of species including primates (Fontana and
Partridge 2015; Mattison et al. 2017). Several of these
studies have looked at the impact of CR on immune-
senescence and have shown benefits including: main-
tenance of the thymic microenvironment, higher
concentrations of circulating naı¨ve T cells, ameliora-
tion of age associated T cell proliferative defects and
improved TCR diversity in mice (Yang et al. 2009)
and monkeys (Messaoudi et al. 2006). Additionally,
age associated accumulation of senescent T cells was
not seen in calorically restricted mice (Spaulding et al.
1997). CR can also modulate the cytokine secretion
profile of T cells, inducing a decrease in TNFa and
IFNc production by T cells in mice (Nikolich-Zugich
and Messaoudi 2005) and suppression of B cell
lymphopoiesis in mice (Tang et al. 2016). However,
studies investigating the impact of CR on infectious
disease susceptibility have yielded contradictory
findings. Effros et al. (1991) reported that aged CR
mice could mount a vigorous response against
influenza, whereas Ritz et al. showed increased
susceptibility to infections in aged CR mice (2006).
CR also affects innate immune cells, but these
effects have been less well studied and the few studies
to date suggest the effects are not universally bene-
ficial. Neutrophil function has been reported to be
unaffected by CR in dogs (Greeley et al. 2006), whilst
a decline in circulating NK cell frequency (Clinthorne
et al. 2013) and NK cell cytotoxicity was seen in CR
mice (Ritz et al. 2008). Leptin, an adipocyte secreted
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hormone plays an important role in maintaining NK
cell numbers (Tian et al. 2002). Leptin levels are
reduced in CR mice, making it a potential candidate
through which immunomodulatory effects of CR are
mediated (Clinthorne et al. 2013). Similar to NK cells,
reductions in circulating DC numbers and DC pro-
genitors in bone marrow have been reported in CR
mice (Duriancik and Gardner 2016).
The high prevalence of centenarians and lower
morbidity from age-associated diseases in Okinawans
is intriguing evidence supporting the view that CR
could also have lifespan and health span benefits in
humans (Willcox et al. 2017). The Okinawans have a
calorie intake that is much lower than their mainland
Japanese peers, related to their beliefs that you should
always leave some food on your plate at the end of a
meal. Children intake approximately 60% of the
recommended calories for a child in the UK and for
adults this is 80% (Willcox et al. 2007). Importantly
Okinawans have significantly reduced incidence of
most cancers that are common in the developed world
including breast, prostate and colon cancer and have
lower levels of dementia (Willcox et al. 2007). There
are currently no data concerning immune function in
Okinawans. There are still very few rigorous clinical
trials involving CR. A National Institute of Aging
sponsored randomized trial of a 2 year caloric restric-
tion regimen in healthy humans (CALERIE) revealed
slowing of biological ageing as evidenced by reduced
cardiovascular disease risk biomarkers and lower
levels of pro-inflammatory cytokines, which has been
associated with decline in body fat mass (Das et al.
2017; Ravussin et al. 2015).
Chronic nutrient excess, particularly a high fat diet
leads to an increase in systemic inflammation, which
over time activates immune cells promoting local
chronic inflammation in metabolic cells such as
adipocytes and hepatocytes (Franceschi et al. 2017).
Thus, it is not surprising that CR, which can result in a
reduction in visceral body fat, may be a promising
anti-inflammaging intervention. CR has been shown to
reduce IL6 levels in old rhesus monkeys (Willette
et al. 2010). IL6 is a known thymosuppressive
cytokine and reducing its levels by CR could be a
contributing factor towards improved thymic output
observed in CR animals (Yang et al. 2009). Thus to
date, CR has shown impact as a dietary intervention
for immunesenescence in animal models but further
studies are required to determine its effects on human
immune ageing and especially if it is beneficial for all
aspects of the immune response.
Nutrition
Optimal nutrition is an important determinant of
healthy ageing and plays a significant role in main-
taining immune function. Malnutrition risk signifi-
cantly increases with age (Elia et al. 2008), possibly
contributing to compromised immune function and
increased infection susceptibility in older adults.
Observational studies have examined the association
between reduced expression of pro-inflammatory
markers and the Mediterranean diet (low in saturated
and high in monounsaturated fats mainly from olive
oil, high in carbohydrates mainly from legumes and
high in fibre) in healthy adults (Chrysohoou et al.
2004). A recent study with 125 older subjects,
RISTOMED, has reported a similar anti-inflammag-
ing effect of a mediterranean diet with or without
supplementation with d-limonene (Ostan et al. 2016).
Increased intake of specific dietary components, such
as omega 3 fatty acids (Molfino et al. 2014) also has
anti-inflammatory effects. Interestingly, the adoption
of the mediterranean diet by older adults has also been
associated improvement in immune responses, partic-
ularly dendritic cell function (Clements et al. 2017).
Another specific dietary component thought to
possess immunomodulating properties are probiotics
(Thomas and Versalovic 2010). Ageing is associated
with a reduction in beneficial microbes in the colon
including Bifidobacteria, countered by a rise in
proteolytic bacteria (Pae et al. 2012). The administra-
tion of B. bifidium exerts an anti-senescence (reduced
p16 expression in thymus and spleen) and anti-
inflammatory effects (lower IL6 and TNFa levels) in
old mice (Fu et al. 2010). A study done on 61 healthy
adults aged[ 65 years reported that probiotic con-
sumption for 6 months increased the number of recent
thymic emigrants and decreased the number of
senescent CD8 CD28null T cells (Moro-Garcı´a et al.
2013). Additionally o an improved cytotoxicity of NK
cells (Gill et al. 2001) and phagocytic activity of
granulocytes (Maneerat et al. 2014) has been reported
with probiotic consumption for 3 weeks in healthy
elderly. Probiotic supplementation for 13 weeks has
also been reported to improve vaccine responses in a
clinical trial done in over 200 subjects[ 70 years
(Boge et al. 2009). Another trial in 1072 healthy old
123
486 Biogerontology (2018) 19:481–496
participants reported a reduced risk of respiratory
infection in participants consuming fermented dairy
product containing probiotics for 3 months (Guille-
mard et al. 2010).
Vitamin D has also emerged as a key modulator of a
range of immune functions including: monocyte
differentiation into macrophages, enhanced phagocy-
tosis by macrophages, reduced production of pro-
inflammatory cytokines by macrophages, suppression
of DC maturation to promote tolerance, inhibition of
Th1 and Th17 responses and regulation of B cell
proliferation (reviewed in Hewison 2010; Vanherwe-
gen et al. 2017). Vitamin D serum levels vary with the
time of year but are also low in older adults (Gallagher
2013). An observational study reported a significant
association between low vitamin D status and markers
of inflammation in older adults (Laird et al. 2014).
Although the potential of Vitamin D supplementation
in reversing immunesenescence still remains largely
unexplored, vitamin D supplementation has been
reported to boost response to acute infections in age-
associated inflammatory disorders (Yin and Agrawal
2014) and improve macrophage antibacterial proper-
ties in chronic kidney disease (Bacchetta et al. 2014).
Zinc is a trace element required for multiple
immune cell tasks including suppression of production
of pro-inflammatory cytokines (IL1b, TNFa) by
monocytes/macrophages and decreasing reactive oxy-
gen species (ROS) (Prasad 2009). A significant
proportion of older adults have low serum zinc levels
due to inadequate intake, impaired metabolism,
infection and inflammation (Pae et al. 2012). Zinc
deficiency has been reported to affect multiple
immune cells and remarkably parallels changes in
immune functioning with age including: impairments
in neutrophil function (Haase and Rink 2009),
macrophage phagocytosis (Rink and Gabriel 2000),
NK cell cytotoxicity (Mocchegiani and Malavolta
2004), thymic involution (Mitchell et al. 2006),
imbalance of Th1/Th2 differentiation (Prasad 2000),
impairments in lymphocyte proliferation, IL2 produc-
tion (Rink and Gabriel 2000) and decreased vaccine
responses (Haase and Rink 2009). Zinc deficient
subjects have also been shown to have greater
susceptibility to pathogens (Walker and Black 2004).
Importantly zinc supplementation has been shown to
reduce infection incidence in older adults (Prasad et al.
2007) and has many effects indicative of reversal of
immunesenescence including: improved NK cell
cytotoxicity (Mocchegiani et al. 2003), modification
of Th1/Th2 balance (Uciechowski et al. 2008),
restoration of serum thymulin activity (Boukaı¨ba
et al. 1993) and improved vaccine responses (Duch-
ateau et al. 1981).
Pharmacological interventions to reduce
immunesenescence
Caloric restriction mimetics
Even though increasing lifespan and improving health
in old age is enormously attractive to most people, a
lifetime commitment to a reduced calorie diet is
unlikely to be adopted at a population level. As a
result, CR mimetics are being sought and several have
already been identified including; Resveratrol (SIRT1
activator), Metformin (AMP kinase activator) and
Rapamycin (mTOR inhibitor).
Resveratrol, a polyphenolic sirtuin activator (De la
Lastra and Villegas 2005) which has been shown to
extend lifespan in several species, occurs naturally in
various plants including red grapes, peanuts and
berries. Although there is not a vast literature on the
impact of resveratrol on immunity in vivo, several
in vitro studies have demonstrated immune modulat-
ing effects, these include a suppressive effect of
resveratrol on neutrophil chemotaxis, superoxide
generation (Cavallaro et al. 2003), T cell proliferation
and cytokine production (Gao et al. 2001) and an
enhancement of NK cell cytotoxicity (Lu and Chen
2010). Resveratrol’s immunomodulating properties
are dose dependent manner, with low concentrations
exerting a positive effect and higher concentrations
being largely inhibitory (Falchetti et al. 2001). Addi-
tionally, anti-inflammatory effects of resveratrol have
been reported in animal studies (Das and Das 2007;
Tung et al. 2015). Another example of resveratrol as
an anti-inflammatory agent has been highlighted in a
study showing that the long-term treatment with
resveratrol significantly attenuated the development
of senescence-associated secretory phenotype (SASP)
in senescent fibroblasts; reducing the release of
proinflammatory cytokines (Pitozzi et al. 2013) by
modulation of mRNA splicing (Latorre et al. 2017).
Resveratrol is inexpensive and commercially avail-
able but studies in healthy humans are currently
limited (Gualdoni et al. 2014).
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Rapamycin (mTOR inhibitor), has emerged as
another candidate that mimics the effects of CR.
Reduced signalling through mTOR has been associ-
ated with increased longevity in invertebrates (Powers
et al. 2006), as well as mammalian species (Harrison
et al. 2009). Rapamycin is used clinically as an
immune suppressant in transplant patients and mTOR
mediated immunosuppression is mediated by modu-
lation of effector and regulatory CD4 T cell subsets
(Araki et al. 2011). To date there has been one placebo
controlled trial in humans that has used low doses of a
m-TOR inhibitor (RAD001) given daily for 6 weeks
before the influenza vaccination in older adults. The
treatment was shown to increase the antibody response
by 20% for 2 out of 3 strains (Mannick et al. 2014)
with few side effects. This drug may have benefits for
immunity in old age as well as broader positive health
effects through mTOR modulation.
Metformin, a treatment for type 2 diabetes, is able
to mimic CR through its activation of AMP kinase and
has also been shown to extend lifespan and healthspan
in several species including rodents (Martin-Montalvo
et al. 2013). Clinical data have also revealed that
diabetics taking metformin have significantly lower
mortality than diabetics on alternative sulphonyl urea
therapies (Campbell et al. 2017). With regard to
immunity, recent clinical studies have reported an
anti-inflammatory role of metformin (Saisho 2015)
and an attenuating effect of metformin on Th17 cell
generation and upregulation of Tregs in mice models
of arthritis (Son et al. 2014).
Reversal of thymic atrophy
Thymic capacity is modulated by a range of positive
(IL7, KGF, GH) and negative (TNF, IL6) factors
(Ventevogel and Sempowski 2013). Thymic regener-
ation or maintenance would be a rational target for
improving immune competence in older adults.
Potential mechanisms for thymic regeneration
include; IL7 or growth hormone replacement therapy
(Aspinall and Mitchell 2008), enhanced keratinocyte
growth factor signalling (Seggewiss et al. 2007).
Studies carried out in old mice have reported that IL7
therapy reversed thymic atrophy, increased thy-
mopoiesis and raised numbers of naı¨ve T cells in
blood (Aspinall et al. 2007; Henson et al. 2005). IL7
administration in preliminary human studies produced
an increase in thymic T cell output and expansion of
naı¨ve T cells in patients with lymphopenia, cancer,
chronic viral infections and following transplant
(Mackall et al. 2011). IL7 has also been identified as
an effective vaccine adjuvant that can augment antigen
specific responses post vaccination recombinant len-
tivector immunised mice (Colombetti et al. 2009). The
clinical evidence so far in humans has suggested that
rhIL7 is safe with minimal side effects (Lundstro¨m
et al. 2012), providing compelling evidence for testing
rhIL7 as a therapeutic agent to restore thymic output in
healthy older adults. Recently IL22 has been identified
as another potential target for restoring thymic func-
tion due to its ability to promote proliferation and
survival of thymic epithelial cells, supporting a
microenvironment required for thymopoiesis
(Chaudhry et al. 2016). Additionally, exogenous
administration of recombinant GH has been reported
to promote thymus regrowth in HIV infected adults
(Napolitano et al. 2008), though the increased risk of
cancer with GH may preclude its long term use.
Statins (HMG-CoA reductase inhibitors)
The beneficial effect of statins in prevention of
cardiovascular events by blocking cholesterol synthe-
sis is well established (Thavendiranathan et al. 2006).
Recent studies have shown that statins also possess
anti-inflammatory properties and can reduce inflam-
matory markers, especially IL6 and CRP both during
chronic inflammatory conditions (Nawawi et al. 2003;
Montecucco and Mach 2009) and also in healthy older
individuals (Mora et al. 2010) and this widely used
drug may be a promising intervention for combating
inflammaging. Our recent data has reported a benefi-
cial of effect of statins in vitro and in vivo in restoring
neutrophil migratory accuracy which declines with
advancing age (Sapey et al. 2017). That this may be
clinically relevant is supported by data showing that
patients admitted to hospital with pneumonia who are
already on statin medication have reduced mortality
compared to those not taking statins (Grudzinska et al.
2017; Bruyere et al. 2014). Additionally, statins are
now also recognised as modulators of telomerase
activity in study conducted on 230 older adults and can
slow telomere shortening, they showed that with every
1 year increment in age a decline by 0.058 Kb was
observed in the no statin group compared with
0.033 Kb in the statin group (Boccardi et al. 2013).
However, a major side effect of using statins that
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needs to be considered is statin-induced myopathy
which is the most common cause of statin discontin-
uation and has been observed in 10–15% of statin
users (Abd and Jacobson 2011).
PI3kinase inhibitors
Neutrophil functions such as chemotaxis, phagocyto-
sis and superoxide generation are regulated via
phosphoinositide 3 kinase (PI3K) activity (Hannigan
et al. 2004). Inaccurate neutrophil chemotaxis in old
donors has been associated with increased constitutive
PI3Kd signalling and inhibitors of this pathway restore
migrational accuracy with no negative effects on other
neutrophil functions (Sapey et al. 2014). PI3K block-
ing therapies offer a new strategy to improve neu-
trophil function in older adults andmight help improve
outcomes during infection and reduce inflammation
(Naccache and Lefebvre 2014). However, one poten-
tial drawback of using PI3K inhibitors is that they
might have a negative effect on other immune cells,
for instance PI3K is required for DC phagocytosis and
migration. Aged DCs in contrast to neutrophils show
decreased activation of the PI3K pathway with age
(Agrawal et al. 2007) and a further suppression might
be detrimental.
p38 MAP kinase inhibition
T cells with senescent characteristics increase with age
and exhibit constitutive p38 MAPK activation (Hen-
son et al. 2015), with recent data revealing that this is
due to formation of a complex between MAP kinases
and the sestrin family of proteins which results in
kinase activation (Lanna et al. 2017). Furthermore,
knockdown of sestrins (Lanna et al. 2017) or inhibition
of p38 MAP kinase (Lanna et al. 2014) restored T cell
proliferative capacity and old sestrin knockout mice
showed improved responses to vaccination compared
with wild type mice (Lanna et al. 2017). Clinical trials
using p38 inhibitors have been tested for a short time
in inflammatory conditions such as rheumatoid arthri-
tis, chronic obstructive pulmonary disease and there
were no reports of increased risk of malignancy
(Patterson et al. 2014), which is a concern in restoring
proliferative capacity more generally. Interestingly
TNFa has been shown to inhibit neutrophil migration
via activation of the p38MAP kinase pathway (Lokuta
and Huttenlocher 2005), suggesting that this pathway
could also targeted to restore age associated defects in
neutrophil function.
IL15 therapy
IL15 is known to play a role in regulating immune
homeostasis and acts as a lymphocyte survival factor,
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especially for naı¨ve T cells (Wallace et al. 2006). IL15
also plays a critical role in the development and
maintenance of NK cells (Cooper et al. 2002) and as
stated above NK cell cytotoxicity declines with age
(Hazeldine et al. 2012). In vitro studies examining the
effect of IL15 on NK cells from acute myeloid
leukaemia patients reported an increase in expression
of NK cell receptors NKp46 and NKp30 (Sanchez-
Correa et al. 2016). Clinical evaluation of IL15 in
cancer therapy has shown to induce expansion of local
T cells and infiltration of long-lived memory T cell
capacity (Pilipow et al. 2015). These findings suggest
the possibility of using cytokine modulation to
improve NK cell responses and increase naı¨ve:
memory T cell ratio in older adults.
Conclusion
The immune system is substantially remodeled with
ageing leading to a decline in efficacy with advancing
age, resulting in increased risk of chronic diseases,
infections, autoimmunity and vaccine failure.
Changes in nutrition and lifestyle can be an effective
approach towards improving immune outcome in
older adults but may be hard to achieve at a population
level (Fig. 3). Research in the field of interventions to
target immune senescence is gathering pace and
improving immune responses such as vaccinations
may be used as an early biomarker for anti-ageing
effects. A wide range of pharmacological agents with
anti-immunesenescence properties have been identi-
fied (Fig. 3) and trials with agents such as rapamycin
analogs are underway. Thus, immunomodulation
represents a promising therapeutic approach to
improve the health of older adults.
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